Temat: "FIBRINOLYTIC agents" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Efficacy and safety of different doses of tenecteplase for the treatment of acute ischemic stroke: A protocol for a systematic review and network meta-analysis.
Autorzy :: Shen T; Department of Neurology, Zhuji Hospital Affiliated to Shaoxing University of Arts and Science, Zhuji, Shaoxing.
Zhou J; Department of Neurology, Zhuji Hospital Affiliated to Shaoxing University of Arts and Science, Zhuji, Shaoxing.
Zhao Y; Department of Neurology, People's Hospital of Banan District of Chongqing, Chongqing, China.; Pokaż więcej
Źródło :: Medicine [Medicine (Baltimore)] 2020 Dec 04; Vol. 99 (49), pp. e23379.
Typ publikacji :: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :: Fibrinolytic Agents/*therapeutic use
Ischemic Stroke/*drug therapy
Tenecteplase/*therapeutic use
Acute Disease ; Bayes Theorem ; Fibrinolytic Agents/administration & dosage ; Fibrinolytic Agents/adverse effects ; Humans ; Randomized Controlled Trials as Topic ; Research Design ; Tenecteplase/administration & dosage ; Tenecteplase/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Antithrombotic therapy for stroke prevention in patients with atrial fibrillation in Japan.
Autorzy :: Maruhashi T; Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University , Hiroshima, Japan.
Higashi Y; Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University , Hiroshima, Japan.; Division of Regeneration and Medicine, Medical Center for Translational and Clinical Research, Hiroshima University Hospital , Hiroshima, Japan.; Pokaż więcej
Źródło :: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2020 Dec; Vol. 21 (17), pp. 2115-2124. Date of Electronic Publication: 2020 Aug 04.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Anticoagulants/*therapeutic use
Atrial Fibrillation/*drug therapy
Fibrinolytic Agents/*therapeutic use
Stroke/*prevention & control
Administration, Oral ; Aged ; Anticoagulants/administration & dosage ; Anticoagulants/adverse effects ; Atrial Fibrillation/complications ; Dose-Response Relationship, Drug ; Female ; Fibrinolytic Agents/administration & dosage ; Fibrinolytic Agents/adverse effects ; Humans ; Japan ; Practice Guidelines as Topic ; Risk Factors ; Stroke/etiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: [Antithrombotics: backgrounds with haemostasis and antithrombotic therapy].
Autorzy :: van Minnen B
Piersma-Wichers M
Rooijers W
van Diermen DE
Rozema FR; Pokaż więcej
Transliterated Title :: Antitrombotica: achtergronden bij stolling en antistolling.
Źródło :: Nederlands tijdschrift voor tandheelkunde [Ned Tijdschr Tandheelkd] 2020 Nov; Vol. 127 (11), pp. 617-624.
Typ publikacji :: Journal Article
MeSH Terms :: Fibrinolytic Agents*/pharmacology
Fibrinolytic Agents*/therapeutic use
Thrombosis*/drug therapy
Thrombosis*/prevention & control
Anticoagulants/pharmacology ; Hemostasis ; Humans ; Netherlands
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Stroke and Thromboprophylaxis in the Era of COVID-19.
Autorzy :: Ma A; Neurosurgery, Royal North Shore Hospital, Sydney, Australia. Electronic address: .
Kase CS; Neurology, Emory University, Atlanta, Georgia, USA.
Shoamanesh A; Neurology, McMaster University, Population Health Research Institute, Hamilton, Canada.
Abdalkader M; Radiology, Boston Medical Center, Boston, Massachusetts, USA.
Pikula A; Neurology, Department of Medicine, University of Toronto, Canada.
Sathya A; Boston University, School of Medicine, Boston, Massachusetts, USA.
Catanese L; Neurology, Hamilton Health Sciences, Hamilton, Canada; McMaster University, School of Medicine, Canada.
Ellis AT; Intensive Care, Royal North Shore Hospital, Sydney, Australia.
Nguyen TN; Neurology, Boston Medical Center, Boston, Massachusetts, USA.; Pokaż więcej
Źródło :: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2021 Jan; Vol. 30 (1), pp. 105392. Date of Electronic Publication: 2020 Oct 09.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Intermittent Pneumatic Compression Devices*/adverse effects
Anticoagulants/*therapeutic use
COVID-19/*drug therapy
Fibrinolytic Agents/*therapeutic use
Stroke/*prevention & control
Thromboembolism/*prevention & control
Thrombosis/*prevention & control
Anticoagulants/adverse effects ; COVID-19/complications ; COVID-19/diagnosis ; Fibrinolytic Agents/adverse effects ; Humans ; Risk Assessment ; Risk Factors ; Stroke/diagnosis ; Stroke/epidemiology ; Thromboembolism/diagnosis ; Thromboembolism/etiology ; Thrombosis/diagnosis ; Thrombosis/etiology ; Treatment Outcome
SCR Protocol :: COVID-19 drug treatment
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Efficacy and safety of intravenous thrombolysis with alteplase for treating acute ischemic stroke at different time windows: A protocol for systematic review and meta-analysis.
Autorzy :: Huang B; First People's Hospital of Qujing City, Qujing, Yunnan province, China.
Qian F
Fan X
Guan S
Zheng Y
Yang J
Xu F; Pokaż więcej
Źródło :: Medicine [Medicine (Baltimore)] 2020 Dec 24; Vol. 99 (52), pp. e23620.
Typ publikacji :: Journal Article
MeSH Terms :: Meta-Analysis as Topic*
Research Design*
Thrombolytic Therapy*/adverse effects
Thrombolytic Therapy*/methods
Fibrinolytic Agents/*administration & dosage
Ischemic Stroke/*drug therapy
Systematic Reviews as Topic/*methods
Tissue Plasminogen Activator/*administration & dosage
Acute Disease ; Administration, Intravenous ; Fibrinolytic Agents/adverse effects ; Humans ; Time Factors ; Tissue Plasminogen Activator/adverse effects ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Proposed recommendations for antithrombotic prophylaxis for children and adolescents with severe infection and/or multisystem inflammatory syndrome caused by SARS-CoV-2.
Autorzy :: Carneiro JDA; Unidade de Hematologia, Departamento de Pediatria, Instituto da Crianca e do Adolescente (ICr), Hospital das Clinicas (HCFMUSP), Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.
Ramos GF; Unidade de Terapia Intensiva, Departamento de Pediatria, Instituto da Crianca e do Adolescente (ICr), Hospital das Clinicas (HCFMUSP), Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.
de Carvalho WB; Unidade de Terapia Intensiva, Departamento de Pediatria, Instituto da Crianca e do Adolescente (ICr), Hospital das Clinicas (HCFMUSP), Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.
Johnston C; Unidade de Terapia Intensiva, Departamento de Pediatria, Instituto da Crianca e do Adolescente (ICr), Hospital das Clinicas (HCFMUSP), Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.
Delgado AF; Unidade de Terapia Intensiva, Departamento de Pediatria, Instituto da Crianca e do Adolescente (ICr), Hospital das Clinicas (HCFMUSP), Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.; Pokaż więcej
Źródło :: Clinics (Sao Paulo, Brazil) [Clinics (Sao Paulo)] 2020 Dec 09; Vol. 75, pp. e2252. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*
Fibrinolytic Agents*/therapeutic use
SARS-CoV-2*
Adolescent ; Child ; Humans ; Systemic Inflammatory Response Syndrome
SCR Disease Name :: pediatric multisystem inflammatory disease, COVID-19 related
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Dental Management of Patients Undergoing Antithrombotic Therapy.
Autorzy :: Felix J
Chaban P
Ouanounou A; Pokaż więcej
Źródło :: Journal (Canadian Dental Association) [J Can Dent Assoc] 2020 Dec; Vol. 86, pp. k17.
Typ publikacji :: Journal Article
MeSH Terms :: Fibrinolytic Agents*/adverse effects
Oral Surgical Procedures*
Anticoagulants/adverse effects ; Dental Care ; Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease.
Autorzy :: Yang Y; Hanlin College, Nanjing University of Traditional Chinese Medicine, Taizhou 225300, China.
Chen J; Hanlin College, Nanjing University of Traditional Chinese Medicine, Taizhou 225300, China.
Gao Q; Hanlin College, Nanjing University of Traditional Chinese Medicine, Taizhou 225300, China.
Shan X; Hanlin College, Nanjing University of Traditional Chinese Medicine, Taizhou 225300, China.
Wang J; Hanlin College, Nanjing University of Traditional Chinese Medicine, Taizhou 225300, China.
Lv Z; Hanlin College, Nanjing University of Traditional Chinese Medicine, Taizhou 225300, China. Electronic address: .; Pokaż więcej
Źródło :: Toxicology [Toxicology] 2020 Dec 01; Vol. 445, pp. 152599. Date of Electronic Publication: 2020 Sep 22.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Diet, High-Fat/*adverse effects
Ferroptosis/*drug effects
Fibrinolytic Agents/*therapeutic use
Ginkgolides/*therapeutic use
Lactones/*therapeutic use
Non-alcoholic Fatty Liver Disease/*drug therapy
Animals ; Ferroptosis/physiology ; Fibrinolytic Agents/pharmacology ; Ginkgolides/pharmacology ; Hep G2 Cells ; Humans ; Lactones/pharmacology ; Lipid Peroxidation/drug effects ; Lipid Peroxidation/physiology ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; NF-E2-Related Factor 2/metabolism ; Non-alcoholic Fatty Liver Disease/etiology ; Non-alcoholic Fatty Liver Disease/metabolism ; Oxidative Stress/drug effects ; Oxidative Stress/physiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Temporal Trends in Pharmacological Stroke Prevention in Patients with Acute Ischemic Stroke and Known Atrial Fibrillation.
Autorzy :: Hellwig S; Klinik für Neurologie mit Experimenteller Neurologie, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, Germany. Electronic address: .
Grittner U; Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Germany; Berlin Institute of Health, Berlin, Germany. Electronic address: .
Herm J; Klinik für Neurologie mit Experimenteller Neurologie, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: .
Ruschmann R; Department of Cardiology, Helios Kliniken Schwerin, Berlin, Germany. Electronic address: .
Konieczny M; Klinik für Neurologie mit Experimenteller Neurologie, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. Electronic address: .
Endres M; Klinik für Neurologie mit Experimenteller Neurologie, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, Germany; Berlin Institute of Health, Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE), Partner site Berlin, Germany; German Centre for Cardiovascular Diseases (DZHK), Partner site Berlin, Germany. Electronic address: .
Haeusler KG; Department of Neurology, Universitätsklinikum Würzburg, Germany. Electronic address: .; Pokaż więcej
Źródło :: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2020 Dec; Vol. 29 (12), pp. 105266. Date of Electronic Publication: 2020 Sep 10.
Typ publikacji :: Journal Article
MeSH Terms :: Anticoagulants/*administration & dosage
Atrial Fibrillation/*drug therapy
Brain Ischemia/*prevention & control
Fibrinolytic Agents/*administration & dosage
Platelet Aggregation Inhibitors/*administration & dosage
Practice Patterns, Physicians'/*trends
Secondary Prevention/*trends
Stroke/*prevention & control
Administration, Oral ; Aged ; Aged, 80 and over ; Anticoagulants/adverse effects ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/epidemiology ; Brain Ischemia/diagnosis ; Brain Ischemia/epidemiology ; Drug Utilization/trends ; Female ; Fibrinolytic Agents/adverse effects ; Germany/epidemiology ; Humans ; Male ; Platelet Aggregation Inhibitors/adverse effects ; Retrospective Studies ; Risk Factors ; Stroke/diagnosis ; Stroke/epidemiology ; Time Factors ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Expanded Indication for Recombinant Tissue Plasminogen Activator from 3 to 4.5 h after Onset of Stroke in Japan.
Autorzy :: Miyamoto Y; Division of Nephrology and Endocrinology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Electronic address: .
Aso S; Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Iwagami M; Department of Health Services Research, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
Morita K; Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Fushimi K; Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan.
Hamasaki Y; Division of Nephrology and Endocrinology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan; Department of Hemodialysis and Apheresis, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Nangaku M; Division of Nephrology and Endocrinology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan; Department of Hemodialysis and Apheresis, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Doi K; Department of Acute Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Yasunaga H; Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.; Pokaż więcej
Źródło :: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2020 Dec; Vol. 29 (12), pp. 105341. Date of Electronic Publication: 2020 Oct 08.
Typ publikacji :: Journal Article; Observational Study
MeSH Terms :: Thrombolytic Therapy*/adverse effects
Time-to-Treatment*
Brain Ischemia/*drug therapy
Fibrinolytic Agents/*administration & dosage
Stroke/*drug therapy
Tissue Plasminogen Activator/*administration & dosage
Aged ; Aged, 80 and over ; Brain Ischemia/diagnosis ; Brain Ischemia/mortality ; Brain Ischemia/physiopathology ; Databases, Factual ; Female ; Fibrinolytic Agents/adverse effects ; Hospital Mortality ; Humans ; Interrupted Time Series Analysis ; Japan ; Male ; Middle Aged ; Recombinant Proteins/administration & dosage ; Recovery of Function ; Retrospective Studies ; Risk Factors ; Stroke/diagnosis ; Stroke/mortality ; Stroke/physiopathology ; Time Factors ; Tissue Plasminogen Activator/adverse effects ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Large-Bore Aspiration Thrombectomy versus Catheter-Directed Thrombolysis for Acute Pulmonary Embolism: A Propensity Score-Matched Comparison.
Autorzy :: Graif A; Department of Vascular and Interventional Radiology, Christiana Care Health System, 4755 Ogletown Stanton Road, Suite 1e20, Newark, DE 19713. Electronic address: .
Patel KD; Department of Vascular and Interventional Radiology, Christiana Care Health System, 4755 Ogletown Stanton Road, Suite 1e20, Newark, DE 19713.
Wimmer NJ; Department of Cardiology, Christiana Care Health System, 4755 Ogletown Stanton Road, Suite 1e20, Newark, DE 19713.
Kimbiris G; Department of Vascular and Interventional Radiology, Christiana Care Health System, 4755 Ogletown Stanton Road, Suite 1e20, Newark, DE 19713.
Grilli CJ; Department of Vascular and Interventional Radiology, Christiana Care Health System, 4755 Ogletown Stanton Road, Suite 1e20, Newark, DE 19713.
Upparapalli D; Department of Cardiology, Christiana Care Health System, 4755 Ogletown Stanton Road, Suite 1e20, Newark, DE 19713.
Kaneria AR; Department of Cardiology, Christiana Care Health System, 4755 Ogletown Stanton Road, Suite 1e20, Newark, DE 19713.
Leung DA; Department of Vascular and Interventional Radiology, Christiana Care Health System, 4755 Ogletown Stanton Road, Suite 1e20, Newark, DE 19713.; Pokaż więcej
Źródło :: Journal of vascular and interventional radiology : JVIR [J Vasc Interv Radiol] 2020 Dec; Vol. 31 (12), pp. 2052-2059. Date of Electronic Publication: 2020 Nov 09.
Typ publikacji :: Comparative Study; Journal Article
MeSH Terms :: Thrombectomy*/adverse effects
Thrombectomy*/mortality
Thrombolytic Therapy*/adverse effects
Thrombolytic Therapy*/mortality
Fibrinolytic Agents/*administration & dosage
Pulmonary Embolism/*therapy
Acute Disease ; Adult ; Aged ; Aged, 80 and over ; Comparative Effectiveness Research ; Female ; Fibrinolytic Agents/adverse effects ; Humans ; Male ; Middle Aged ; Propensity Score ; Pulmonary Embolism/diagnostic imaging ; Pulmonary Embolism/mortality ; Pulmonary Embolism/physiopathology ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Suction ; Time Factors ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19.
Autorzy :: Talukdar J; Synthetic Biology Group, Reliance Research & Development Centre, Reliance Industries Limited, Navi Mumbai, Maharashtra, 400701, India. Electronic address: .
Bhadra B; Synthetic Biology Group, Reliance Research & Development Centre, Reliance Industries Limited, Navi Mumbai, Maharashtra, 400701, India.
Dattaroy T; Synthetic Biology Group, Reliance Research & Development Centre, Reliance Industries Limited, Navi Mumbai, Maharashtra, 400701, India.
Nagle V; Synthetic Biology Group, Reliance Research & Development Centre, Reliance Industries Limited, Navi Mumbai, Maharashtra, 400701, India.
Dasgupta S; Synthetic Biology Group, Reliance Research & Development Centre, Reliance Industries Limited, Navi Mumbai, Maharashtra, 400701, India.; Pokaż więcej
Źródło :: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2020 Dec; Vol. 132, pp. 110886. Date of Electronic Publication: 2020 Oct 16.
Typ publikacji :: Journal Article; Review
MeSH Terms :: COVID-19/*drug therapy
Cytokines/*antagonists & inhibitors
Fibrinolytic Agents/*therapeutic use
SARS-CoV-2/*drug effects
Animals ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; COVID-19/blood ; COVID-19/immunology ; Cytokines/blood ; Cytokines/immunology ; Fibrinolytic Agents/pharmacology ; Humans ; Risk Factors ; SARS-CoV-2/immunology ; Xanthophylls/pharmacology ; Xanthophylls/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Managing Ischemic Stroke in Patients Already on Anticoagulation for Atrial Fibrillation: A Nationwide Practice Survey.
Autorzy :: Salehi Omran S; Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University Medical College, New York, NY, United States; Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, NY, United States. Electronic address: .
Parikh NS; Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University Medical College, New York, NY, United States; Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, NY, United States.
Zambrano Espinoza M; Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University Medical College, New York, NY, United States.
Lerario MP; Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, NY, United States.
Levine SR; Departments of Neurology and Emergency Medicine, State University of New York Downstate Health Sciences University, New York, NY, United States; Department of Neurology, Kings County Hospital Center, Brooklyn, NY, United States.
Kamel H; Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, NY, United States.
Marshall R; Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University Medical College, New York, NY, United States.
Willey J; Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University Medical College, New York, NY, United States.; Pokaż więcej
Źródło :: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2020 Dec; Vol. 29 (12), pp. 105291. Date of Electronic Publication: 2020 Sep 11.
Typ publikacji :: Journal Article
MeSH Terms :: Anticoagulants/*administration & dosage
Atrial Fibrillation/*drug therapy
Brain Ischemia/*therapy
Fibrinolytic Agents/*administration & dosage
Neurologists/*trends
Practice Patterns, Physicians'/*trends
Stroke/*therapy
Administration, Oral ; Anticoagulants/adverse effects ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/epidemiology ; Brain Ischemia/diagnostic imaging ; Brain Ischemia/epidemiology ; Drug Substitution/trends ; Drug Utilization/trends ; Fibrinolytic Agents/adverse effects ; Health Care Surveys ; Humans ; Medication Adherence ; Platelet Aggregation Inhibitors/administration & dosage ; Stroke/diagnostic imaging ; Stroke/epidemiology ; Treatment Outcome ; United States/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Reader response: MT in anticoagulated patients: Direct oral anticoagulants versus vitamin K antagonists.
Autorzy :: Frontera JA; (New York).; Pokaż więcej
Źródło :: Neurology [Neurology] 2020 Nov 17; Vol. 95 (20), pp. 939-940.
Typ publikacji :: Journal Article; Comment
MeSH Terms :: Anticoagulants*/adverse effects
Fibrinolytic Agents*
Humans ; Vitamin K
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Optimizing Monotherapy Selection, Aspirin Versus P2Y12 Inhibitors, Following Percutaneous Coronary Intervention.
Autorzy :: Yerasi C; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Case BC; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Forrestal BJ; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Torguson R; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Weintraub WS; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Garcia-Garcia HM; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Waksman R; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia. Electronic address: .; Pokaż więcej
Źródło :: The American journal of cardiology [Am J Cardiol] 2020 Nov 15; Vol. 135, pp. 154-165. Date of Electronic Publication: 2020 Aug 15.
Typ publikacji :: Comparative Study; Journal Article; Review
MeSH Terms :: Percutaneous Coronary Intervention*
Aspirin/*administration & dosage
Dual Anti-Platelet Therapy/*methods
Fibrinolytic Agents/*administration & dosage
Hemorrhage/*prevention & control
Postoperative Complications/*prevention & control
Purinergic P2Y Receptor Antagonists/*administration & dosage
Algorithms ; Aspirin/adverse effects ; Fibrinolytic Agents/adverse effects ; Hemorrhage/chemically induced ; Humans ; Time Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data.
Autorzy :: Thomalla G; Klinik und Poliklinik für Neurologie, Kopf- und Neurozentrum, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. Electronic address: .
Boutitie F; Hospices Civils de Lyon, Service de Biostatistique, Lyon, France; Université Lyon 1, Villeurbanne, France; Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique-Santé, Villeurbanne, France.
Ma H; Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, VIC, Australia.
Koga M; Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Ringleb P; Department of Neurology, University of Heidelberg, Heidelberg, Germany.
Schwamm LH; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Wu O; Athinoula A Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA.
Bendszus M; Department of Neuroradiology, University of Heidelberg, Heidelberg, Germany.
Bladin CF; Department of Neurosciences, Eastern Health and Eastern Health Clinical School, Monash University, Box Hill, VIC, Australia.
Campbell BCV; Departments of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia.
Cheng B; Klinik und Poliklinik für Neurologie, Kopf- und Neurozentrum, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Churilov L; Departments of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia.
Ebinger M; Centrum für Schlaganfallforschung Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany; Klinik für Neurologie Medical Park Berlin Humboldtmühle, Berlin, Germany.
Endres M; Centrum für Schlaganfallforschung Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany; Klinik und Hochschulambulanz für Neurologie, Charité-Universitätsmedizin Berlin, Berlin, Germany; German Centre of Cardiovascular Research, Berlin, Germany; German Center of Neurodegenerative Diseases, Berlin, Germany.
Fiebach JB; Centrum für Schlaganfallforschung Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Fukuda-Doi M; Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan; Department of Data Science, National Cerebral and Cardiovascular Center, Suita, Japan.
Inoue M; Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Kleinig TJ; Department of Neurology, Royal Adelaide Hospital, Adelaide, SA, Australia.
Latour LL; Acute Cerebrovascular Diagnostics Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Lemmens R; Department of Neurosciences, Experimental Neurology, KU Leuven, University of Leuven, Leuven, Belgium; VIB Center for Brain and Disease Research Leuven, Belgium; Department of Neurology, University Hospitals Leuven, Leuven, Belgium.
Levi CR; The Department of Neurology, Priority Research Centre for Brain and Mental Health Research, John Hunter Hospital, University of Newcastle, Newcastle, NSW, Australia.
Leys D; Université de Lille, Inserm U1171, Lille, France.
Miwa K; Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Molina CA; Stroke Unit, Department of Neurology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Muir KW; Institute of Neuroscience and Psychology, University of Glasgow, Glasgow, UK.
Nighoghossian N; Department of Stroke Medicine, Université Claude Bernard Lyon 1, CarMeN Laboratory, INSERM U1060/INRA 1397, Lyon, France.
Parsons MW; Departments of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia.
Pedraza S; Department of Radiology, Institut de Diagnòstic per la Imatge, Hospital Dr Josep Trueta, Institut d'Investigació Biomèdica de Girona, Girona, Spain.
Schellinger PD; Universitätsklinik für Neurologie, Mühlenkreiskliniken, Johannes Wesling Klinikum Minden, Universitätsklinikum der Ruhr-Universität Bochum, Minden, Germany.
Schwab S; Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.
Simonsen CZ; Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Song SS; Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Thijs V; Florey Institute of Neuroscience and Mental Health, Heidelberg, VIC, Australia; Department of Neurology, Austin Health, Heidelberg, VIC, Australia.
Toni D; Department of Human Neurosciences, University of Rome 'La Sapienza', Rome, Italy.
Hsu CY; Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan.
Wahlgren N; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Yamamoto H; Center for Advancing Clinical and Translational Sciences, National Cerebral and Cardiovascular Center, Suita, Japan.
Yassi N; Departments of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia; Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Yoshimura S; Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Warach S; Dell Medical School, University of Texas at Austin, Austin, TX, USA.
Hacke W; Department of Neurology, University of Heidelberg, Heidelberg, Germany.
Toyoda K; Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Donnan GA; Departments of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia.
Davis SM; Departments of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia.
Gerloff C; Klinik und Poliklinik für Neurologie, Kopf- und Neurozentrum, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.; Pokaż więcej
Corporate Authors :: Evaluation of unknown Onset Stroke thrombolysis trials (EOS) investigators
Źródło :: Lancet (London, England) [Lancet] 2020 Nov 14; Vol. 396 (10262), pp. 1574-1584. Date of Electronic Publication: 2020 Nov 08.
Typ publikacji :: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :: Time-to-Treatment*
Fibrinolytic Agents/*therapeutic use
Ischemic Stroke/*diagnostic imaging
Ischemic Stroke/*drug therapy
Tissue Plasminogen Activator/*therapeutic use
Diffusion Magnetic Resonance Imaging/methods ; Fibrinolytic Agents/adverse effects ; Humans ; Infusions, Intravenous ; Recovery of Function ; Tissue Plasminogen Activator/adverse effects ; Tomography, X-Ray Computed/methods ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: The thromboprotective effect of traditional Chinese medicine Tongji 2 granules is dependent on anti-inflammatory activity by suppression of NF-κB pathways.
Autorzy :: Zhou L; Department of Cardiology, Tongji Hospital of Tongji University, Shanghai, China.
Lapping S; Case Cardiovascular Research Institute, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States of America.
Liao X; Case Cardiovascular Research Institute, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States of America.
Lu Y; Case Cardiovascular Research Institute, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States of America.
Zhou G; Case Cardiovascular Research Institute, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States of America.
Matoba K; Division of Diabetes, Endocrinology, and Metabolism, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Vasudevan N; Case Cardiovascular Research Institute, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States of America.
Wang L; Department of Cardiology, Tongji Hospital of Tongji University, Shanghai, China.
Nayak L; Division of Hematology and Oncology, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States of America.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2020 Nov 12; Vol. 15 (11), pp. e0241607. Date of Electronic Publication: 2020 Nov 12 (Print Publication: 2020).
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :: Anti-Inflammatory Agents/*pharmacology
Drugs, Chinese Herbal/*pharmacology
Endothelial Cells/*drug effects
Fibrinolytic Agents/*pharmacology
NF-kappa B/*metabolism
Venous Thrombosis/*drug therapy
Animals ; Anti-Inflammatory Agents/therapeutic use ; Cells, Cultured ; Drugs, Chinese Herbal/therapeutic use ; Endothelial Cells/metabolism ; Endothelium, Vascular/cytology ; Fibrinolytic Agents/therapeutic use ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; RAW 264.7 Cells
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 18 18.

Tytuł :: Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis.
Autorzy :: Hasan SS; School of Applied Sciences, University of Huddersfield, Huddersfield, UK. .
Radford S; Intensive Care Unit, Austin Health, Melbourne, Australia.; School of Medicine, University of Melbourne, Melbourne, Australia.
Kow CS; School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia.
Zaidi STR; School of Healthcare, University of Leeds, Leeds, UK.; Leeds Teaching Hospitals Trust, Leeds, UK.; Pokaż więcej
Źródło :: Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2020 Nov; Vol. 50 (4), pp. 814-821.
Typ publikacji :: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :: Anticoagulants/*administration & dosage
Blood Coagulation/*drug effects
Coronavirus Infections/*drug therapy
Fibrinolytic Agents/*administration & dosage
Pneumonia, Viral/*drug therapy
Venous Thromboembolism/*prevention & control
Aged ; Anticoagulants/adverse effects ; Betacoronavirus/pathogenicity ; COVID-19 ; Coronavirus Infections/blood ; Coronavirus Infections/epidemiology ; Coronavirus Infections/virology ; Critical Illness ; Female ; Fibrinolytic Agents/adverse effects ; Host-Pathogen Interactions ; Humans ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/blood ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/virology ; Risk Factors ; SARS-CoV-2 ; Time Factors ; Treatment Outcome ; Venous Thromboembolism/blood ; Venous Thromboembolism/epidemiology ; Venous Thromboembolism/virology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19.
Autorzy :: Carneiro T; Department of Neurology, Boston University School of Medicine, 72 East Concord Street, Collamore C3 Neurology, Boston, MA 02118, United States.
Dashkoff J; Department of Neurology, Boston University School of Medicine, 72 East Concord Street, Collamore C3 Neurology, Boston, MA 02118, United States.
Leung LY; Department of Neurology, Stroke and Cerebrovascular Diseases Division, Tufts Medical Center, Boston, MA, United States.
Nobleza COS; Department of Neurology, Neuroscience Critical Care Division, University of Mississippi Medical Center, Jackson, MS, United States.
Marulanda-Londono E; Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, United States.
Hathidara M; Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, United States.
Koch S; Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, United States.
Sur N; Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, United States.
Boske A; Department of Neurology, Saint David's Round Rock Medical Center, Round Rock, TX, United States.
Voetsch B; Department of Neurology, Lahey Hospital and Medical Center, Burlington, MA, United States.
Aboul Nour H; Department of Neurology, Henry Ford Hospital, Wayne State University, Detroit, MI, United States.
Miller DJ; Department of Neurology, Henry Ford Hospital, Wayne State University, Detroit, MI, United States.
Daneshmand A; Department of Neurology, Boston University School of Medicine, 72 East Concord Street, Collamore C3 Neurology, Boston, MA 02118, United States.
Shulman J; Department of Neurology, Boston University School of Medicine, 72 East Concord Street, Collamore C3 Neurology, Boston, MA 02118, United States.
Curiale G; Department of Neurology, Boston University School of Medicine, 72 East Concord Street, Collamore C3 Neurology, Boston, MA 02118, United States.
Greer DM; Department of Neurology, Boston University School of Medicine, 72 East Concord Street, Collamore C3 Neurology, Boston, MA 02118, United States.
Romero JR; Department of Neurology, Boston University School of Medicine, 72 East Concord Street, Collamore C3 Neurology, Boston, MA 02118, United States; NHLBI's Framingham Heart Study, Framingham, MA, United States.
Anand P; Department of Neurology, Boston University School of Medicine, 72 East Concord Street, Collamore C3 Neurology, Boston, MA 02118, United States. Electronic address: .
Cervantes-Arslanian AM; Department of Neurology, Boston University School of Medicine, 72 East Concord Street, Collamore C3 Neurology, Boston, MA 02118, United States.; Pokaż więcej
Źródło :: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2020 Nov; Vol. 29 (11), pp. 105201. Date of Electronic Publication: 2020 Jul 27.
Typ publikacji :: Journal Article; Multicenter Study
MeSH Terms :: Thrombolytic Therapy*/adverse effects
Brain Ischemia/*drug therapy
Coronavirus Infections/*therapy
Fibrinolytic Agents/*administration & dosage
Pneumonia, Viral/*therapy
Stroke/*drug therapy
Tissue Plasminogen Activator/*administration & dosage
Administration, Intravenous ; Aged ; Aged, 80 and over ; Brain Ischemia/diagnosis ; Brain Ischemia/epidemiology ; COVID-19 ; Coronavirus Infections/diagnosis ; Coronavirus Infections/epidemiology ; Female ; Fibrinolytic Agents/adverse effects ; Humans ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/epidemiology ; Risk Factors ; Stroke/diagnosis ; Stroke/epidemiology ; Thrombectomy ; Time Factors ; Tissue Plasminogen Activator/adverse effects ; Treatment Outcome ; United States/epidemiology ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report.
Autorzy :: Zanon E; Medicine Department, Haemophilia Centre, Padua University Hospital, Via Giustiniani, 35128, Padua, Italy. .
Pasca S; Medicine Department, Haemophilia Centre, Padua University Hospital, Via Giustiniani, 35128, Padua, Italy.
Campello E; Centre for Haemorrhagic and Thrombotic Diseases, Medicine Department, Padua University Hospital, Padua, Italy.
Spiezia L; Centre for Haemorrhagic and Thrombotic Diseases, Medicine Department, Padua University Hospital, Padua, Italy.
Vettor R; Medicine Department (DIMED), Padua University Hospital, Padua, Italy.
Simioni P; Centre for Haemorrhagic and Thrombotic Diseases, Medicine Department, Padua University Hospital, Padua, Italy.; Pokaż więcej
Źródło :: Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2020 Nov; Vol. 50 (4), pp. 795-798. Date of Electronic Publication: 2020 Jul 16.
Typ publikacji :: Case Reports
MeSH Terms :: Blood Coagulation/*drug effects
Coronavirus Infections/*therapy
Enoxaparin/*administration & dosage
Fibrinolytic Agents/*administration & dosage
Hemophilia A/*complications
Pneumonia, Viral/*therapy
Thrombosis/*prevention & control
Aged ; Betacoronavirus/pathogenicity ; COVID-19 ; Coronavirus Infections/blood ; Coronavirus Infections/complications ; Coronavirus Infections/virology ; Enoxaparin/adverse effects ; Female ; Fibrinolytic Agents/adverse effects ; Hemophilia A/blood ; Host-Pathogen Interactions ; Humans ; Pandemics ; Pneumonia, Viral/blood ; Pneumonia, Viral/complications ; Pneumonia, Viral/virology ; SARS-CoV-2 ; Thrombosis/blood ; Thrombosis/diagnosis ; Thrombosis/virology ; Treatment Outcome
: Raport

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""FIBRINOLYTIC agents"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język